Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

6 results

Sort by

List item

Human medicine European public assessment report (EPAR): Gilenya (updated)

fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011, , , Revision: 27, Authorised, Last updated: 18/12/2020
List item

Human medicine European public assessment report (EPAR): Xeljanz

tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013, , , Revision: 15, Authorised, Last updated: 14/12/2020
List item

Human medicine European public assessment report (EPAR): Picato

Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012, , , Revision: 10, Withdrawn, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Lemtrada

alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013, , , Revision: 10, Authorised, Last updated: 21/07/2020
List item

Human medicine European public assessment report (EPAR): Xarelto

rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008, , , Revision: 32, Authorised, Last updated: 17/01/2020
List item

Human medicine European public assessment report (EPAR): Lartruvo

Olaratumab, Sarcoma
Date of authorisation: 09/11/2016, , , , , Revision: 3, Withdrawn, Last updated: 02/09/2019